Influenza virus interferon-inducing particle efficiency is reversed in avian and mammalian cells, and enhanced in cells Co-infected with defective-interfering particles

Journal of Interferon and Cytokine Research

Volumn 32, Issue 6, 2012, Pages 280-285

  Ngunjiri, John M ^a   Lee, Chang Won ^b,c   Ali, Ahmed ^b,c   Marcus, Philip I ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON INDUCING AGENT; MESSENGER RNA; NONSTRUCTURAL PROTEIN 1; RNA POLYMERASE; RNA POLYMERASE II; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CHICKEN; DEFECTIVE VIRUS; HAPLORHINI; HOST CELL; INFLUENZA VIRUS; INTERFERON INDUCTION; INTERFERON PRODUCTION; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; QUANTUM YIELD; RNA TRANSCRIPTION; VIRUS CELL INTERACTION;

ANIMALS; CHICKENS; DEFECTIVE VIRUSES; INFLUENZA VACCINES; INTERFERONS; MAMMALS; MOLECULAR DYNAMICS SIMULATION; ORTHOMYXOVIRIDAE; PHENOTYPE;

EID: 84862182731     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0102     Document Type: Article

References (33)

1. Akkina RK, Chambers,TM, Nayak DP. 1984. Mechanism of interference by defective-interfering particles of influenza virus: differential reduction of intracellular synthesis of specific polymerase proteins. Virus Res 1:687-702. (Pubitemid 15195316)
2. Baum A, Sachidanandam R, Garc?́a-Sastre A. 2010. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci U S A 107:16303-16308.
3. Bean WJ, Kawaoka Y, Wood JM, Pearson JE, Webster RG. 1985. Characterization of virulent and avirulent A/Chicken/Pennsylvania/ 83 influenza A viruses: potential role of defective interfering RNAs in nature. J Virol 54:151-160. (Pubitemid 15136857)
4. Bracci L, Canini I, Puzelli S, Sestili P, Vanditti M, Spada M, Donatelli I, Belardelli F, Proietti E. 2005. Type I interferon is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level. Vaccine 23:2994-3004. (Pubitemid 40462438)
5. Cauthen AN, Swayne DE, Sekellick MJ, Marcus PI, Suarez DL. 2007. Amelioration of influenza virus pathogenesis in chickens is attributed to the enhanced interferon-inducing capacity of a virus with a truncated NS1 gene. J Virol 61: 1838-1847. (Pubitemid 46214456)
6. Chambers, TM, Webster, RG. 1987. Defective interfering virus associated with A/chicken/Pennsylvania-83 influenza virus. J Virol 61:1517-1523. (Pubitemid 17069757)
7. Dimmock NJ, Rainsford EW, Scott PE, Marriott AC. 2008. Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. J Virol 82:8570-8578.
8. Easton AJ, Scott PD, Edworthy NL, Meng B, Marriott AC, Dimmock NJ. 2011. A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo. Vaccine 29:2777-2784.
9. Graef KM, Vreede FT, LauY-F, McCall AW, Carr SM, Subbarao K, Fodor E. 2010. The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. J Virol 84:8433-8445.
10. Hai R, Martinez-Sobrido L, Fraser KA, Ayllon J, Garcia-Sastre A, Palese P. 2008. Influenza B virus NS1-truncated mutants: liveattenuated vaccine approach. J Virol 82:10580-10590. (Pubitemid 352691164)
11. Hale BG, Randall RE, Ortin J, Jackson D. 2008. The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89:2359-2376.
12. Iwai A, Shiozaki T, Kawai T, Akira S. Kawaoka Y, Takada A, Kida H, Miyazaki T. 2010. Influenza A virus polymerase inhibits type I interferon induction by binding to interferon b promoter stimulator 1. J Biol Chem 285:32064-32074.
13. Kochs G, Garc?́a-Sastre A, Martinez-Sobrido L. 2007. Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 81:7011-7021. (Pubitemid 46986637)
14. Lee C-W, Suarez DL. 2008. Reverse genetics of the avian influenza virus. Methods Mol Biol 436:99-111.
15. Malinoski CP, Marcus PI. 2012. Influenza virus: a single noninfectious interferon induction-suppressing particle blocks ex-pression of interferon-inducing particles. J Interferon Cytokine Res 32(3):121-126.
16. Marcus PI. 1986. Interferon induction dose-response curves. Methods Enzymol 119:106-114.
17. Marcus PI, Gershick T, van der Heide L, Sekellick MJ. 2007. Super-sentinel chickens detect low-pathogenicity influenza virus. Emerg Infect Dis 13:1608-1610. (Pubitemid 350007008)
18. Marcus PI, Ngunjiri JM, Sekellick MJ. 2009. Dynamics of biologically active subpopulations in influenza virus: plaqueforming, noninfectious cell-killing, and defective-interfering particles. J Virol 83:8122-8130.
19. Marcus PI, Ngunjiri JM, Sekellick MJ, Wang L, Lee C-W. 2010. In Vitro analysis of virus particle subpopulations in candidate live-Attenuated influenza vaccines distinguishes effective from ineffective vaccines. J Virol 84:10974-10981.
20. Marcus PI, Rojek JM, Sekellick M J. 2005. Interferon induction and/or production and its suppression by influenza A viruses. J Virol 79:2880-2890. (Pubitemid 40270566)
21. Ngunjiri JM, Sekellick MJ, Marcus PI. 2008. Clonogenic assay of type A influenza viruses reveals noninfectious cell-killing (apoptosis-inducing) particles. J Virol 82:2673-2680. (Pubitemid 351329158)
22. Portnoy J, Merigan TC. 1971. The effect of interferon and interferon inducers on avian influenza. J Infect Dis 124:2425-2432.
23. Richt JA, Garc?́a-Sastre A. 2009. Attenuated influenza virus vaccines with modified NS1 proteins. Curr Top Microbiol Immunol 333:177-195.
24. Rodriguez A, Pérez-González A, Hossain MJ, Chen L-M, Rolling T, Pérez-Brena P, Donis R, Kochs G, Nieto A. 2009. Attenuated strains of influenza virus A viruses do not induce degradation of RNA poymerase II. J Virol 83:1166-1174.
25. Rodriguez A, Perez-Gonzalez A, Nieto A. 2007. Influenza virus infection causes specific degradation of the largest subunit of cellular RNA polymerase II. J Virol 81:5315-5324. (Pubitemid 46744440)
26. Sekellick MJ, Carra SA, Bowman A, Hopkins DA, Marcus, PI. 2000. Transient resistance of influenza virus to interferon action attributed to random multiple packaging and activity of NS genes. J Interferon Cytokine Res 20:963-970.
27. Sekellick MJ, Ferrandino AF, Hopkins DA, Marcus PI. 1994. Chicken interferon gene: cloning, expression, and analysis. J Interferon Res 14:71-79. (Pubitemid 24292447)
28. Sekellick MJ, Marcus PI. 1986. Induction of high titer chicken interferon. Methods Enzymol 119:115-125. (Pubitemid 16025103)
29. Vreede FT, Fodor E. 2010. The role of the influenza virus RNA polymerase in host shut-off. Virulence 1:436-439.
30. Wang L, Suarez DL, Pantin-Jackwood M, Mibayashi M, Garc?́a-Sastre A, Saif YM, Lee C-W. 2008. Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry. Vaccine 26:3580-3586.
31. Wang Z, Robb NC, Lenz E, Wolff T, Fodor E, Pleschka S. 2010. NS reassortment of an H7-type highly pathogenic avian influenza virus affects its propagation by altering the regulation of viral RNA production and antiviral host response, J Virol 84:11323-11335.
32. Wolff T, Ludwig S. 2009. Influenza viruses control the vertebrate type I interferon systems: factors, mechanisms, and consequences. J Interferon Cytokine Res 29:549-557.
33. Zhou B, Li Y, Belser JA, Pearce MB, Schmolke M, Subba AX, Shi Z, Zaki SR, Blau DM, Garc?́a-Sastre A, Tumpey TM, Wentworth DE. 2010. NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets. Vaccine 28:8015-8025.